Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wassim W Labaki

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
JCI Insight|January 3, 2020
Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohortWilliam Z Zhang, Michelle C Rice, Katherine L Hoffman, et al.
JCI Insight|June 24, 2024
Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohortWilliam Z Zhang, Michelle C Rice, Katherine L Hoffman, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 15, 2021
Genetic variation in genes regulating skeletal muscle regeneration and tissue remodelling associated with weight loss in chronic obstructive pulmonary diseasePreeti Lakshman Kumar, Ava C Wilson, Alison Rocco, et al.
Annals of the American Thoracic Society|June 1, 2026
Association Between Chronic PM2.5 Exposure and CT-Detected Lung Abnormalities in the SPIROMICS CohortChristopher B Bosma, Lantian Xu, Susan Murray, et al.
Chest|February 4, 2021
Ratio of FEV<sub>1</sub>/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung FunctionSpyridon Fortis, Alejandro P Comellas, Surya P Bhatt, et al.
American Journal of Respiratory and Critical Care Medicine|June 22, 2026
Airway Mucus Plugs in Asthma and COPD: Pathobiology, Imaging, and Implications for Clinical TrialsChristopher B Bosma, Shawn D Aaron, Bartolome R Celli, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|May 18, 2023
Changes in Lung Volumes with Spirometric Disease Progression in COPDMehrdad Arjomandi, Siyang Zeng, Jianhong Chen, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 19, 2024
Design of the SPIROMICS Study of Early COPD Progression: SOURCE StudyJeffrey L Curtis, Lori A Bateman, Susan Murray, et al.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
Dynamic and prognostic proteomic associations with FEV<sub>1</sub> decline in chronic obstructive pulmonary diseaseLisa Ruvuna, Kahkeshan Hijazi, Daniel E Guzman, et al.
Scientific Reports|May 22, 2023
A blood and bronchoalveolar lavage protein signature of rapid FEV<sub>1</sub> decline in smoking-associated COPDKatarina M DiLillo, Katy C Norman, Christine M Freeman, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
JCI Insight|January 3, 2020
Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohortWilliam Z Zhang, Michelle C Rice, Katherine L Hoffman, et al.
JCI Insight|June 24, 2024
Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohortWilliam Z Zhang, Michelle C Rice, Katherine L Hoffman, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 15, 2021
Genetic variation in genes regulating skeletal muscle regeneration and tissue remodelling associated with weight loss in chronic obstructive pulmonary diseasePreeti Lakshman Kumar, Ava C Wilson, Alison Rocco, et al.
Annals of the American Thoracic Society|June 1, 2026
Association Between Chronic PM2.5 Exposure and CT-Detected Lung Abnormalities in the SPIROMICS CohortChristopher B Bosma, Lantian Xu, Susan Murray, et al.
Chest|February 4, 2021
Ratio of FEV<sub>1</sub>/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung FunctionSpyridon Fortis, Alejandro P Comellas, Surya P Bhatt, et al.
American Journal of Respiratory and Critical Care Medicine|June 22, 2026
Airway Mucus Plugs in Asthma and COPD: Pathobiology, Imaging, and Implications for Clinical TrialsChristopher B Bosma, Shawn D Aaron, Bartolome R Celli, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|May 18, 2023
Changes in Lung Volumes with Spirometric Disease Progression in COPDMehrdad Arjomandi, Siyang Zeng, Jianhong Chen, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 19, 2024
Design of the SPIROMICS Study of Early COPD Progression: SOURCE StudyJeffrey L Curtis, Lori A Bateman, Susan Murray, et al.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
Dynamic and prognostic proteomic associations with FEV<sub>1</sub> decline in chronic obstructive pulmonary diseaseLisa Ruvuna, Kahkeshan Hijazi, Daniel E Guzman, et al.
Scientific Reports|May 22, 2023
A blood and bronchoalveolar lavage protein signature of rapid FEV<sub>1</sub> decline in smoking-associated COPDKatarina M DiLillo, Katy C Norman, Christine M Freeman, et al.
Pageof 10